Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

NCT01049945 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma

Interventions

DRUG: bendamustine hydrochloride
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

Mayo Clinic